SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

Ripple's XRP is facing intense market scrutiny as it struggles to maintain the psychological support level of $1.00, triggering a heated debate among investors regarding its long-term utility versus potential long-term price suppression.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital is currently trending as the community reacts to the company securing critical construction permits for its Texas data center project, a milestone investors believe significantly de-risks the development. While some remain cautious due to recent earnings volatility and the lack of a finalized tenant, bulls are actively discussing the site's potential for off-grid, behind-the-meter power as a major competitive advantage in the AI infrastructure market.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors focus on an anticipated earnings catalyst, with the community closely tracking potential revenue growth and the impact of significant short interest on the stock's volatility. The discussion centers on the company's progress in AI infrastructure projects in Southeast Asia and the strategic significance of upcoming financial disclosures in driving a possible revaluation.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending due to active buyout negotiations involving Stripe and Advent International, with investors speculating that a higher, revised offer is necessary to satisfy shareholders. The community is heavily debating fair valuation, with many vocal traders arguing that any bid below $75$80 is a lowball effort for a cash-rich company, while others remain focused on technical breakouts and potential insider positioning.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis is trending as investors monitor its recent NYSE uplisting and the impact of the ongoing DEA rescheduling hearings, which remain a primary catalyst for potential federal regulatory shifts. The community is actively debating the stock's long-term potential, with bullish sentiment focused on the company's growth in emerging medical markets and bearish concerns regarding recent insider share sales and sector-wide volatility.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heavy volatility as investors weigh the potential for a massive short squeeze against concerns over pending binary trial readouts. The community remains intensely focused on the upcoming LUGANO trial results, with sentiment divided between high expectations for clinical success and caution regarding the stock's significant short interest and option market activity.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear Tire & Rubber Co. is attracting significant community attention as investors debate its potential as an undervalued turnaround play, fueled by cost-cutting initiatives and speculation about possible mergers or institutional acquisitions. While some traders are actively accumulating shares and highlighting the stock's low valuation relative to historical levels and its role in automotive and military sectors, others remain cautious, pointing to high debt levels and ongoing market manipulation concerns.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind the company's recent strategic settlement with Samsung and aggressive new legal actions against other industry giants. The community is focused on the potential for further patent licensing deals and a possible move to a major exchange, creating widespread bullish sentiment among long-term shareholders.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened volatility and investor debate following an aggressive short report that raised concerns about the company's operational permits and financials, prompting bullish investors to highlight record earnings, record margins, and significant insider buying as evidence of the firm's strength. Community members are divided, with some pointing to the strong production fundamentals and expected contract resolution as reasons to hold, while others express frustration over recent price declines and the uncertainty surrounding the ongoing operations status.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is capturing significant market attention following a strong earnings report and management's optimistic outlook for its lung cancer pipeline, fueling a potential short squeeze with nearly 100 million shares currently shorted. The community is actively debating the stock's transition toward double-digit valuations, driven by the recent institutional accumulation and the expectation of upcoming catalysts related to frontline melanoma and NSCLC data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

QuidelOrtho (QDEL) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered

QuidelOrtho beats Q2 earnings and revenue estimates, but cuts its 2026 outlook on persistent China weakness and a softer respiratory testing environment.

QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging

QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging...

Here's How ABT Broadens Diagnostics Growth Base With Oncology Expansion

Abbott broadens Diagnostics growth with Exact Sciences, as Cancer Diagnostics gains and resilient routine testing offset respiratory weakness.

QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates

QuidelOrtho (QDEL) delivered earnings and revenue surprises of +425.00% and +2.65%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

QuidelOrtho Reports Second Quarter 2026 Financial Results

QuidelOrtho Reports Second Quarter 2026 Financial Results QuidelOrtho Reports Second Quarter 2026 Financial Results PR Newswire SAN DIEGO, Aug. 6, 2026 Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth Excluding China, total revenue grew 6...

Implied Volatility Surging for QuidelOrtho Stock Options

Investors need to pay close attention to QDEL stock based on the movements in the options market lately.

Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates

Lilly (LLY) delivered earnings and revenue surprises of +39.43% and +13.38%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

TEM Q2 Loss Narrower Than Expected, Revenues Beat, Stock Up

Tempus AI climbs 6.6% after its second-quarter loss narrows, revenues beat estimates and 2026 sales guidance rises on diagnostics and data growth.

ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise

Align Technology shares rise after Q2 earnings and revenues beat estimates, fueled by record Clear Aligner shipments and wider non-GAAP margins.

QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.

QuidelOrtho Corporation

QDEL Stock Eyes Best Day In Over A Year — Point-Of-Care Sale Talks Ignite Rally

Equity

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$14.30
Prev Close	$15.09
Open	$14.86
Dividend Yield	0.00%
50-Day Moving Average	$15.74
Beta	1.50
Avg. Volume	1.13M
PE Ratio	-0.98

52-Week High	$35.58
52-Week Low	$9.92
Market Capitalization	$1.03B
EPS (Annual)	-$16.69
Price to Book	0.58
Revenue Per Employee	$419,538.46

Feed

News

Sentiment

Earnings

Fundamentals

Info